RECURSION PHARMACEUTICALS INC CLAS (RXRX)
Sector: Health Care
Sector: Health Care
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Christopher Gibson former Chief Executive Officer and President and current Chair of the Board | 2025 | $680,000 | $0 | $3,808,302 | $4,846,699 | $256,777 | $15,731 | $9,607,508 |
| 2024 | $600,000 | $0 | $3,364,500 | $4,274,816 | $241,865 | $18,405 | $8,499,587 | |
| 2023 | $560,833 | $0 | $3,478,140 | $4,328,352 | $224,483 | $21,400 | $8,613,209 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Najat Khan current Chief Executive Officer and President | 2025 | $600,000 | $0 | $1,944,547 | $2,501,058 | $256,777 | $46,683 | $5,349,065 |
| 2024 | $285,000 | $500,000 | $3,647,774 | $4,592,021 | $115,824 | $54,185 | $9,194,805 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Ben Taylor Chief Financial Officer | 2025 | $538,680 | $0 | $253,881 | $323,110 | $205,226 | $7,586 | $1,328,483 |
| 2024 | $53,392 | $0 | $2,255,389 | $5,662,543 | $200,327 | $0 | $8,171,651 |